Sorting startup wedges from noise in Q3 2026 commercial payer bulletins on UHC stage 3 Tzield, Cigna glioma LITT, infusion site of care, Elevance off-campus billing and Georgia gold cards

Payer bulletins are where reimbursement actually moves. An FDA approval says a drug can be sold. A line in a medical policy says one insurer will cover it for a patient with specific lab values starting on a specific date. Q3 2026 had five changes worth knowing about.

United Healthcare added a stage 3 type 1 diabetes pathway for Tzield, effective October…